Evidence map›Paper›PMID 41528520›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026

Screening for distress among metastatic breast cancer patients at a tertiary cancer center in Southwest Nigeria: Using the NCCN distress thermometer.

Adewumi Alabi, Abdulrazzaq Lawal, Olamijulo Fatiregun, Tolulope Falowo, Bolanle Adegboyega, Adedayo Joseph, Anthonia Sowunmi, Oluwaseun Adebayo Bamodu, Sylvia Shirima, Donaldson F Conserve

Abstract read
PubMed Publisher
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Adewumi Alabi *Department of Radiation Biology, Radiotherapy & Radiodiagnosis, College of Medicine, University of Lagos, Lagos, Nigeria. adealabi@unilag.edu.ng.
Abdulrazzaq LawalDepartment of Surgery, College of Medicine, University of Lagos, Lagos, Nigeria.
Olamijulo FatiregunDepartment of Psychiatry, Lagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria.
Tolulope FalowoCancerAware Nigeria, Lagos, Nigeria.
Bolanle AdegboyegaNSIA-LUTH Cancer Centre, Lagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria.
Adedayo JosephNSIA-LUTH Cancer Centre, Lagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria.
Anthonia SowunmiDepartment of Radiation Biology, Radiotherapy & Radiodiagnosis, College of Medicine, University of Lagos, Lagos, Nigeria.
Oluwaseun Adebayo Bamodu *Bethesda Achievers Consultancy, LLC, Bethesda, MD, USA.
Sylvia ShirimaMilken Institute School of Public Health, The George Washington University, Washington, DC, USA.
Donaldson F ConserveDepartment of Prevention and Community Health, Milken Institute School of Public Health, The George Washington University, Washington, DC, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMetastatic breast cancer (MBC) patients in low- and middle-income countries (LMICs) face unique psychosocial challenges due to advanced disease presentation, financial burdens, and limited access to supportive care. Psychological distress (PD), a critical determinant of treatment adherence and quality of life, remains under-recognized and under-treated in these settings. The Distress Thermometer (DT), a simple screening tool endorsed by the National Comprehensive Cancer Network (NCCN), offers potential for systematic PD assessment.

objectiveThis study assessed the performance of the DT in identifying PD among MBC patients and evaluated its correlation with clinical and sociodemographic factors at a tertiary cancer center (NSIA-LUTH) in Lagos, Southwest Nigeria.

methodsA cross-sectional study was conducted involving 313 patients diagnosed with metastatic breast cancer. Eligible participants, aged ≥ 18 years and cognitively intact, completed the DT alongside a comprehensive problem checklist. Psychological distress was defined as a DT score ≥ 4. Sociodemographic, clinical, and psychosocial data were retrieved from electronic medical records.

resultsThe median age of participants was 53 years, with 98.7% being female. The most common metastatic sites were lungs (53.0%), spine (48.2%), and liver (13.4%). Triple-negative breast cancer was predominant (51.1%). Moderate to severe distress (DT score ≥ 4) was identified in 46% of patients. Primary concerns included insurance-related issues (73.2%), treatment-related concerns (62.3%), and transportation difficulties (59.4%). Psychological manifestations were dominated by worry (62.3%) and anhedonia (50.8%). Physical symptom burden was substantial, with sleep disturbance (57.2%), pain (56.2%), and eating difficulties (52.4%) being most prevalent. Strong family-based support systems were noted, with 75% of patients having primary caregivers. Patients experienced an average of 2.81 concurrent psychosocial challenges and 4.36 concurrent physical symptoms.

conclusionPsychological distress is highly prevalent (46%) among MBC patients in this LMIC setting, driven by insurance-related concerns, transportation difficulties, and substantial symptom burden.. The DT successfully identified patients with clinically significant distress (DT ≥ 4), supporting its feasibility for routine psychosocial screening in resource-limited oncology settings.

Indexed as

Breast NeoplasmsMass ScreeningPsychological DistressStress, PsychologicalAdultAgedCross-Sectional StudiesFemaleHumansMiddle AgedNeoplasm MetastasisNigeriaQuality of LifeTertiary Care CentersLMICMetastatic breast cancerNCCN distress thermometerNigeriaPsychological distressPsychosocial oncologySupportive care

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.